Oncology & Cancer

An epigenetic marker can predict survival in childhood leukaemia

A molecular epigenetic marker is important for distinguishing patients with childhood leukaemia at high and low risk of relapse even at the time of diagnosis. It can be important to adapt early on as to what treatment to ...

page 1 from 6